GE Healthcare (China) Co., Ltd. recalls SIGNA MR355
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- For certain MR systems, a scan can be resumed following a Power Monitor trip when the "6-minute average SAR" is above the limit indicated on the "SAR Display". The user interface may incorrectly enable a scan to proceed earlier than intended. If resumed by the operator, such a scan can result in potential excessive tissue heating, especially if the patient is in contact with a conductive material or has an implant.
- Products
-
- SIGNA MR355
- Where it was sold
-
Domestic US distribution nationwide. International distribution worldwide.
Nationwide
- Barcodes
008406821444070019527836125700840682144445- Units affected
- 241
- About this recall
- SIGNA MR355, SIGNA MR360, NMRI system